Results 101 to 110 of about 12,857 (206)

Valproic acid–induced hyperammonemia: Incidence, clinical significance, and treatment management

open access: yes, 2018
Introduction: Valproic acid (VPA)–induced hyperammonemia poses several clinical challenges in psychiatric medicine. The reported incidence of this adverse effect varies widely across the literature.
Nick Stauner   +2 more
core   +1 more source

Carnitine in Valproate-Induced Hyperammonemia

open access: yes, 1996
The effect of carnitine supplementation in valproic acid (VPA) treated patients presenting with hyperammonemia was investigated in 69 children and young adults seen at the Zentrum der Kinderheilkunde, Goethe-Universitat Frankfurt, and Universitat ...
Millichap, Joseph Gordon   +2 more
core   +1 more source

Targeting autophagy for therapy of hyperammonemia

open access: yes, 2018
Ammonia is a highly neurotoxic metabolite that is efficiently converted into urea or glutamine. During liver failure due to hepatocellular dysfunction or in inherited deficiencies of urea cycle enzymes, ammonia clearance is impaired resulting in systemic
Brunetti-Pierri, Nicola   +1 more
core   +1 more source

Ammonia, infection and inflammation in hepatic encephalopathy. [PDF]

open access: yes, 2007
For over a century, we have known that ammonia is important in the pathogenesis of hepatic encephalopathy. Studies in patients with acute liver failure have shown rapid progression to severe encephalopathy in those patients with evidence of a systemic ...
Shawcross, D.L.   +1 more
core  

Hyperornithinemia–Hyperammonemia–Homocitrullinuria Syndrome in Vietnamese Patients

open access: yes
Background and Objectives: Hyperornithinemia–hyperammonemia–homocitrullinuria syndrome (HHH; OMIM 238970) is one of the rare urea cycle disorders.
Ngoc Lan Nguyen   +11 more
core   +1 more source

The Toll of Hyperammonemia on the Brain [PDF]

open access: yesCellular and Molecular Gastroenterology and Hepatology, 2019
Saunders, Justin M.   +2 more
openaire   +2 more sources

Hyperammonemia in children treated with asparaginase for acute lymphoblastic leukaemia

open access: yes
International audienceBackground: Asparaginase is a key component of pediatric acute lymphoblastic leukemia (ALL) chemotherapy. Hyperammonemia is a known side effect of this treatment, but its clinical implications in this population are poorly ...
Damaj, Lena   +6 more
core   +1 more source

Hyperammonemia in neonatologist practice

open access: yes, 2020
The neonatal hyperammonemia is the pathological condition that occurs during the neonatal period; it is characterized by the increased content of the free ammonium ions in the blood, and it causes the severe neurological disorders.
Degtyareva A. V.
core  

Home - About - Disclaimer - Privacy